D-0789-2026 Class II Ongoing

Recalled by Lupin Pharmaceuticals Inc. — Naples, FL

FDA drug recall D-0789-2026 was initiated by Lupin Pharmaceuticals Inc. on Aug 3, 2026 and is designated Class II. Reason for recall: Failed content uniformity specifications. The recall status is ongoing. Affected quantity: 5082 tubes.

Recall details

Product Type
Drugs
Report Date
Sep 2, 2026
Initiation Date
Aug 3, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5082 tubes

Product description

Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, United States, Manufactured by: Lupin Limited, Pithampur (MP) 454 775, INDIA, NDC 68180-956-04.

Reason for recall

Failed content uniformity specifications.

Distribution pattern

USA Nationwide

Code information

Lot#: KB00427, Exp date 4/30/2028; KA00308, Exp date 10/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0789-2026
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Lupin Pharmaceuticals Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0789-2026. Report a data issue: hello@regdatalab.com.